FDA Inspection
Binod Dhakal, MDBinod Dhakal, MD – FDA Inspection, Jun 26, 2026
Record Details
This FDA Inspection record concerns Binod Dhakal, MD, with an inspection on June 26, 2026, issued by the Minneapolis District Office, covering biologics.
View Company Profile
ID · d7826343-7b1e-42f7-8f2d-112657b6a70a
Inspection Facts
- Inspection number
- 1323738
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Binod Dhakal, MD
1| Date | Classification | Office | Project area |
|---|---|---|---|
| November 17, 2023 | NAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
Other documents for Binod Dhakal, MD
- FDA Inspection 1224651 - 2023-11-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.